A gamma camera re-evaluation of potassium iodide blocking efficiency in mice

Health Physics

Volumn 92, Issue 4, 2007, Pages 396-406

  Hammond, William T ^a   Bradley, Eric L ^a   Welsh, Robert E ^a   Qian, Jianguo ^a   Weisenberger, Andrew G ^b   Smith, Mark F ^b   Majewski, Stan ^b   Saha, Margaret S ^a  

^a Dept of Economics and Thomas Jefferson Program in Public Policy at the College of William and Mary   (United States)

^b THOMAS JEFFERSON NATIONAL ACCELERATOR FACILITY   (United States)

Author keywords

125I; Iodine; Mice; Potassium iodide

Indexed keywords

IODINE 125; POTASSIUM IODIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; RADIATION FIELD; RADIATION MEASUREMENT; RADIATION PROTECTION; RADIOACTIVITY; SCINTILLATION CAMERA; THYROID GLAND;

ADMINISTRATION, ORAL; ANIMALS; GAMMA CAMERAS; HUMANS; IODINE RADIOISOTOPES; MICE; MICE, INBRED C57BL; POTASSIUM IODIDE; RADIATION INJURIES, EXPERIMENTAL; RADIOPHARMACEUTICALS; THYROID GLAND; TISSUE DISTRIBUTION; WHOLE-BODY COUNTING;

MUS;

EID: 33947136871     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.HP.0000252322.45350.ee     Document Type: Article

References (31)

1. Bacher K, Brans B, Monsieurs M, De Winter F, Dierckx R, Thierens H. Thyroid uptake and radiation dose after 131I-lipiodol treatment: Is thyroid blocking by potassium iodide necessary? Eur J Nucl Med Mol Imaging 29:1311-1316; 2002.
2. 131I by potassium iodide. JAMA 200:112-116; 1967.
3. Brans B, Monsieurs M, Laureys G, Kaufman J, Thierens H, Dierckx R. Thyroidal uptake and radiation dose after repetitive I-131-MIBG treatments: influence of potassium iodide for thyroid blocking. Med Pediatr Oncol 38:41- 46; 2002.
4. Bruno R, Giannasio P, Ronga G, Baudin E, Travagli JP, Russo D, Filetti S, Schlumberger M. Sodium iodide symporter expression and radioiodine distribution in extrathyroidal tissues. J Endocrinol Invest 27:1010-1014; 2004.
5. 131I in childhood. J Natl Cancer Inst 97:724-732; 2005.
6. Fish WA, Carlin H, Hickey FC. The thyroidal uptake, retention and iodine pool in rats under controlled iodide diet. Endocrinol 51:282-292; 1952.
7. Franic Z. Iodine prophylaxis and nuclear accidents. Arh Hig Rada Toksikol 50:223-233; 1999.
8. Heltemes LM, Hagan CR, Mitrofanova EE, Panchal RG, Guo J, Link CJ. The rat sodium iodide symporter gene permits more effective radioactive concentration than the human sodium iodide symporter gene in human and rodent cancer cells. Cancer Gene Ther 10:14-22; 2003.
9. Il'in L, Arkhangel'skaya G, Konstaninov Y, Likhtarev I. Radioactive iodine in the problem of radiation safety. Atomizdat 1972. (Available from Springfield, VA: Translation series US-AEC 7536, National Technical Information Service 208-229; 1972.)
10. Josefsson M, Grunditz T, Ohlsson T, Ekblad E. Sodium/iodide symporter: distribution in different mammals and role in entero-thyroid circulation of iodide. Acta Physiol Scan 175:129-137; 2002.
11. Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chernobyl. Nature 359:21-22; 1992.
12. Lee JM, Zemans RL, Hejazi M, Chin BB, Ladenson PW, Caturegli P. Modulation of thyroidal radioiodine uptake by theophylline. Exper Mol Path 77:116-120; 2004.
13. Lewandowsik TA, Seeley MR, Beck BD. Interspecies differences in susceptibility to perturbation of thyroid homeostasis: a case study with perchlorate. Regulatory Toxicol Pharmacol 39:348-362; 2004.
14. Noteboom JL, Hummel WA, Broerse JJ, de Vijlder JJ, Vulsma T, van Bekkum DW. Protection of the infant thyroid from radioactive contamination by the administration of stable iodide. An experimental evaluation in chimpanzees. Radiat Res 147:698-703; 1997.
15. 131I uptake by the thyroid in rats. Health Phys 65:545-549; 1993.
16. Pahuja DN, Jagtap VS, Sonawane VR, Rajan MGR, Samuel AM. Calcium iodate - another effective blocker of radioiodine uptake by the thyroid gland. Health Phys 89:92-94; 2005.
17. Ribela MT, Marone MM, Bartolini P. Use of radioiodine urinalysis for effective thyroid blocking in the first few hours post exposure. Health Phys 76:11-16; 1999.
18. Rivkees SA, Sklar C, Freemark M. The management of Graves' Disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 83:3767-3776; 1998.
19. Saha MS, Bradley EL, Brewer P, Gleason KK, Kross B, Majewski S, Popov V, Qian J, Ranck A, Smith K, Smith MF, Weisenberger AG, Wojcik R, Welsh RE. Incorporation of a fluoroscopic x-ray modality in a small animal imaging system. IEEE Trans Nucl Sci 50:333-338; 2003.
20. Saxena KM, Chapman EM, Pryles CV. Minimal dosage of iodide required to suppress uptake of iodine-131 by normal thyroid. Science 138:430-431; 1962.
21. Selmi-Ruby S, Watrin C, Trouttet-Masson S, Bernier-Valentin F, Flachon V, Munari-Silem Y, Rousset B. The porcine sodium/iodied symporter gene exhibits an uncommon expression pattern related to the use of alternative splice sites not present in the human or murine species. Endocrinol 144:1074-1085; 2003.
22. Sternthal E, Lipworth L, Stanley B, Abreau C, Fang S, Braverman L. Suppression of thyroid radioiodine uptake by various doses of stable iodide. N Engl J Med 303:1083-1088; 1980.
23. Takamura N, Nakamura Y, Ishigaki K, Ishigaki J, Mine M, Aoyagi K, Yamashita S. Thyroid blockade during a radiation emergency in iodine-rich areas: effect of a stable-iodine dosage. J Radiat Res 45:201-204; 2004.
24. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance: potassium iodide as a thyroid blocking agent in radiation emergencies. Rockville, MD: US DHHS, FDA, CDER; 2001.
25. van Santen HM, de Kraker J, van Eck BLF, de Vijlder JJM, Vulsma T. Improved radiation protection of the thyroid gland with thyroxine, methimazole, and potassium iodide during diagnostic and therapeutic use of radiolabeled metaiodobenzylguanidine in children with neuroblastoma. Cancer 98:389-396; 2003.
26. Weisenberger AG, Wojcik R, Bradley EL, Brewer P, Majewski S, Qian J, Ranck A, Saha MS, Smith K, Smith MF, Welsh RE. SPECT-CT system for small animal imaging. IEEE Trans Nucl Sci 50:74; 2003.
27. Wooten R, Hammond BJ. A computer simulation study of optimal thyroid radiation protection during investigations involving the administration of radioiodine-labeled pharmaceuticals. Br J Radiol 51:265-272; 1978.
28. World Health Organization. Guidelines for iodine prophylaxis following nuclear accidents, 1999 update. Geneva: WHO; 1999.
29. Zhang Z, Liu YY, Jhiang SM. Cell surface targeting accounts for the difference in iodide uptake between human Na+/I-symporter and rat Na+/I- symporter. J Clin Endocrinol Metab 90:6131-6140; 2005.
30. 131I antibody therapy. Cancer Biother Radiopharm 13:457-460; 1998.
31. Zuckier LS, Dohan O, Li Y, Chang CJ, Carrasco N, Dadachova E. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo. J Nucl Med 45:500-507; 2004.